KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Other financing activities (2016 - 2025)

Historic Other financing activities for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to -$11.0 million.

  • Quest Diagnostics' Other financing activities fell 46666.67% to -$11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.0 million, marking a year-over-year increase of 7777.78%. This contributed to the annual value of $21.0 million for FY2024, which is 5000.0% up from last year.
  • Latest data reveals that Quest Diagnostics reported Other financing activities of -$11.0 million as of Q3 2025, which was down 46666.67% from $11.0 million recorded in Q2 2025.
  • Over the past 5 years, Quest Diagnostics' Other financing activities peaked at $57.0 million during Q4 2024, and registered a low of -$61.0 million during Q1 2025.
  • Moreover, its 5-year median value for Other financing activities was -$1.5 million (2022), whereas its average is -$5.7 million.
  • Its Other financing activities has fluctuated over the past 5 years, first tumbled by 107500.0% in 2021, then surged by 24444.44% in 2023.
  • Quarter analysis of 5 years shows Quest Diagnostics' Other financing activities stood at $21.0 million in 2021, then tumbled by 195.24% to -$20.0 million in 2022, then skyrocketed by 190.0% to $18.0 million in 2023, then surged by 216.67% to $57.0 million in 2024, then crashed by 119.3% to -$11.0 million in 2025.
  • Its Other financing activities was -$11.0 million in Q3 2025, compared to $11.0 million in Q2 2025 and -$61.0 million in Q1 2025.